The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Breast Neoplasms, Male

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Breast Neoplasms, Male


High impact information on Breast Neoplasms, Male


Chemical compound and disease context of Breast Neoplasms, Male


Biological context of Breast Neoplasms, Male


Anatomical context of Breast Neoplasms, Male


Gene context of Breast Neoplasms, Male


Analytical, diagnostic and therapeutic context of Breast Neoplasms, Male


  1. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Couch, F.J., Farid, L.M., DeShano, M.L., Tavtigian, S.V., Calzone, K., Campeau, L., Peng, Y., Bogden, B., Chen, Q., Neuhausen, S., Shattuck-Eidens, D., Godwin, A.K., Daly, M., Radford, D.M., Sedlacek, S., Rommens, J., Simard, J., Garber, J., Merajver, S., Weber, B.L. Nat. Genet. (1996) [Pubmed]
  2. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Stratton, M.R., Ford, D., Neuhasen, S., Seal, S., Wooster, R., Friedman, L.S., King, M.C., Egilsson, V., Devilee, P., McManus, R. Nat. Genet. (1994) [Pubmed]
  3. Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer. Olsson, H., Ranstam, J. J. Natl. Cancer Inst. (1988) [Pubmed]
  4. A case of brain metastases from male breast cancer responding to tamoxifen. van Rijswijk, R.E., van Oostenbrugge, R.J., Twijnstra, A. Eur. J. Cancer (1997) [Pubmed]
  5. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Ross, J.S., Fletcher, J.A. Stem Cells (1998) [Pubmed]
  6. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Meijers-Heijboer, H., van den Ouweland, A., Klijn, J., Wasielewski, M., de Snoo, A., Oldenburg, R., Hollestelle, A., Houben, M., Crepin, E., van Veghel-Plandsoen, M., Elstrodt, F., van Duijn, C., Bartels, C., Meijers, C., Schutte, M., McGuffog, L., Thompson, D., Easton, D., Sodha, N., Seal, S., Barfoot, R., Mangion, J., Chang-Claude, J., Eccles, D., Eeles, R., Evans, D.G., Houlston, R., Murday, V., Narod, S., Peretz, T., Peto, J., Phelan, C., Zhang, H.X., Szabo, C., Devilee, P., Goldgar, D., Futreal, P.A., Nathanson, K.L., Weber, B., Rahman, N., Stratton, M.R. Nat. Genet. (2002) [Pubmed]
  7. Male breast cancer and the androgen receptor gene. Lobaccaro, J.M., Lumbroso, S., Belon, C., Galtier-Dereure, F., Bringer, J., Lesimple, T., Heron, J.F., Pujol, H., Sultan, C. Nat. Genet. (1993) [Pubmed]
  8. Tamoxifen and male breast cancer. Cantwell, B.M., Tong, D., Minton, M., Rubens, R.D., Hayward, J.L. Lancet (1978) [Pubmed]
  9. Letter: Familial male breast cancer. Teasdale, C., Forbes, J.F., Baum, M. Lancet (1976) [Pubmed]
  10. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Friedman, L.S., Gayther, S.A., Kurosaki, T., Gordon, D., Noble, B., Casey, G., Ponder, B.A., Anton-Culver, H. Am. J. Hum. Genet. (1997) [Pubmed]
  11. BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription. Shin, S., Verma, I.M. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  12. Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer. Pegoraro, R.J., Nirmul, D., Joubert, S.M. Cancer Res. (1982) [Pubmed]
  13. Clinical correlations of steroid receptors and male breast cancer. Everson, R.B., Lippman, M.E., Thompson, E.B., McGuire, W.L., Wittliff, J.L., De Sombre, E.R., Jensen, E.V., Singhakowinta, A., Brooks, S.C., Neifeld, J.P. Cancer Res. (1980) [Pubmed]
  14. Response to megestrol in male breast carcinoma. Mitsuyasu, R., Bonomi, P., Anderson, K., Fischer, W. Arch. Intern. Med. (1981) [Pubmed]
  15. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Serova, O.M., Mazoyer, S., Puget, N., Dubois, V., Tonin, P., Shugart, Y.Y., Goldgar, D., Narod, S.A., Lynch, H.T., Lenoir, G.M. Am. J. Hum. Genet. (1997) [Pubmed]
  16. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival. Pich, A., Margaria, E., Chiusa, L. J. Clin. Oncol. (2000) [Pubmed]
  17. Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer. Kwiatkowska, E., Teresiak, M., Breborowicz, D., Mackiewicz, A. Int. J. Cancer (2002) [Pubmed]
  18. Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer. Tirkkonen, M., Kainu, T., Loman, N., Jóhannsson, O.T., Olsson, H., Barkardóttir, R.B., Kallioniemi, O.P., Borg, A. Genes Chromosomes Cancer (1999) [Pubmed]
  19. CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status. Gudmundsdottir, K., Thorlacius, S., Jonasson, J.G., Sigfusson, B.F., Tryggvadottir, L., Eyfjord, J.E. Br. J. Cancer (2003) [Pubmed]
  20. High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. Csokay, B., Udvarhelyi, N., Sulyok, Z., Besznyak, I., Ramus, S., Ponder, B., Olah, E. Cancer Res. (1999) [Pubmed]
  21. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. Sasano, H., Kimura, M., Shizawa, S., Kimura, N., Nagura, H. J. Clin. Endocrinol. Metab. (1996) [Pubmed]
  22. Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer. Prechtel, D., Werenskiold, A.K., Prechtel, K., Keller, G., Höfler, H. Diagn. Mol. Pathol. (1998) [Pubmed]
  23. Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient without any detectable BRCA2 germline mutation. Adeyinka, A., Mertens, F., Bondeson, L., Garne, J.P., Borg, A., Baldetorp, B., Pandis, N. Cancer Genet. Cytogenet. (2000) [Pubmed]
  24. Mortality among urban policemen in Rome. Forastiere, F., Perucci, C.A., Di Pietro, A., Miceli, M., Rapiti, E., Bargagli, A., Borgia, P. Am. J. Ind. Med. (1994) [Pubmed]
  25. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. Kwiatkowska, E., Teresiak, M., Filas, V., Karczewska, A., Breborowicz, D., Mackiewicz, A. Clin. Cancer Res. (2003) [Pubmed]
  26. CHEK2 1100delC is not a risk factor for male breast cancer population. Syrjäkoski, K., Kuukasjärvi, T., Auvinen, A., Kallioniemi, O.P. Int. J. Cancer (2004) [Pubmed]
  27. Frequent amplification and overexpression of CCND1 in male breast cancer. Bärlund, M., Kuukasjärvi, T., Syrjäkoski, K., Auvinen, A., Kallioniemi, A. Int. J. Cancer (2004) [Pubmed]
  28. Detection and purification of a novel 72 kDa glycoprotein male breast tumor associated antigen. Basu, A., Basu, I., Chakraborty, A., Pal, S., Chattopadhyay, U. Int. J. Cancer (2003) [Pubmed]
  29. A polymorphism in the CYP17 gene is associated with male breast cancer. Young, I.E., Kurian, K.M., Annink, C., Kunkler, I.H., Anderson, V.A., Cohen, B.B., Hooper, M.L., Wyllie, A.H., Steel, C.M. Br. J. Cancer (1999) [Pubmed]
  30. Tamoxifen response following no response to orchiectomy in metastatic male breast cancer: a case report. Hilliard, D.A., Wilbur, D.W., Camacho, E.S. Journal of surgical oncology. (1984) [Pubmed]
  31. Expression of BRCA1 and BRCA2 in male breast cancers and gynecomastias. Bernard-Gallon, D.J., Déchelotte, P.J., Le Corre, L., Vissac-Sabatier, C., Favy, D.A., Cravello, L., De Latour, M.P., Bignon, Y.J. Anticancer Res. (2003) [Pubmed]
  32. A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen. Tanaka, Y., Ohmori, Y., Toki, T., Okazaki, Y., Ogoshi, S., Ogawa, Y. Nippon geka hokan. Archiv für japanische Chirurgie. (1995) [Pubmed]
WikiGenes - Universities